phenyl-n-tert-butylnitrone and Syndrome

phenyl-n-tert-butylnitrone has been researched along with Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durand, G; Geromel, V; Ouari, O; Polidori, A; Pucci, B; Rustin, P; Tordo, P1
Blazar, BR; Drobyski, WR; Gendelman, M; Halligan, N; Komorowski, R; Logan, B; Murphy, WJ; Pritchard, KA1

Other Studies

2 other study(ies) available for phenyl-n-tert-butylnitrone and Syndrome

ArticleYear
Synthesis and preliminary biological evaluations of ionic and nonionic amphiphilic alpha-phenyl-N-tert-butylnitrone derivatives.
    Journal of medicinal chemistry, 2003, Nov-20, Volume: 46, Issue:24

    Topics: Adenosine Triphosphatases; Ataxia; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Fibroblasts; Free Radical Scavengers; Humans; Hydrophobic and Hydrophilic Interactions; Mitochondrial Myopathies; Mutation; Nitrogen Oxides; Reactive Oxygen Species; Retinitis Pigmentosa; Structure-Activity Relationship; Syndrome

2003
Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration.
    Blood, 2005, Jan-01, Volume: 105, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow Transplantation; CD40 Antigens; Cyclic N-Oxides; Cytokines; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nitrogen Oxides; Survival Rate; Syndrome; Transplantation

2005